Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Wright

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Iscience|April 18, 2023
CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignanciesThuLe Trinh, William A Adams, Alexandra Calescibetta, et al.
JCI Insight|November 18, 2021
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myelomaAgm Mostofa, Allison Distler, Mark B Meads, et al.
Blood|November 22, 2019
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasmsLanzhu Yue, Vasundhara Sharma, Nathan P Horvat, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Iscience|April 18, 2023
CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignanciesThuLe Trinh, William A Adams, Alexandra Calescibetta, et al.
JCI Insight|November 18, 2021
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myelomaAgm Mostofa, Allison Distler, Mark B Meads, et al.
Blood|November 22, 2019
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasmsLanzhu Yue, Vasundhara Sharma, Nathan P Horvat, et al.
Pageof 5